The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
Abstract
Protein carbonylation induced by reactive carbonyl species (RCS) generated by peroxidation of polyunsaturated fatty acids plays a significant role in the etiology and/or progression of several human diseases, such as cardiovascular (e.g., atherosclerosis, long‐term complications of diabetes) and neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, and cerebral ischemia). Most of the biological effects of intermediate RCS, mainly α,β‐unsaturated aldehydes, di‐aldehydes, and keto‐aldehydes, are due to their capacity to react with the nucleophilic sites of proteins, forming advanced lipoxidation end‐products (ALEs). Because of the emerging deleterious role of RCS/protein adducts in several human diseases, different potential therapeutic strategies have been developed in the last few years. This review sheds focus on fundamental studies on lipid‐derived RCS generation, their biological effects, and their reactivity with proteins, with particular emphasis to 4‐hydroxy‐trans‐2‐nonenal (HNE)‐, acrolein (ACR)‐, malondialdehyde (MDA)‐, and glyoxal (GO)‐modified proteins. It also discusses the recently developed pharmacological approaches for the management of chronic diseases in which oxidative stress and RCS formation are massively involved. Inhibition of ALE formation, based on carbonyl‐sequestering agents, seems to be the most promising pharmacological tool and is reviewed in detail. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 6, 817–868, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Metformin monotherapy for type 2 diabetes mellitus
Saenz, A., Fernandez-Esteban, I., Mataix, A., Ausejo Segura, M., Roqué i Figuls, M., & Moher, D. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002966.pub3 · Cited by 308
RetractedSowell, J. G., Frei, B. B., & Stevens, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408433102 · Cited by 33
RetractedChemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. W. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,793
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Tietz Textbook of Clinical Chemistry
(1999) · Archives of Pathology and Laboratory Medicine · doi:10.5858/123.7.646b · Cited by 2,495
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Free radical-mediated oxidation of free amino acids and amino acid residues in proteins
Stadtman, E. R., & Levine, R. L. (2003) · Amino Acids · doi:10.1007/s00726-003-0011-2 · Cited by 1,962
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P. C., Douglas, J. S., Ferguson, T. B., Fihn, S. D., Fraker, T. D., Gardin, J. M., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02848-6 · Cited by 1,689
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“Oral administration of the metal chelator clioquinol inhibits b-amyloid accumulation in an AD transgenic mouse model, by chelating copper that accelerates b-amyloid deposition and protein oxidation by the peptide.(221) More recently clioquinol has been demonstrated to delay AD progression in a small double-blind human…”
BackgroundThe role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,366
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
Thornalley, P. J., LANGBORG, A., & Minhas, H. S. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440109 · Cited by 1,243
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Protein carbonylation in human diseases
Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., & Milzani, A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00031-5 · Cited by 961
Self-citationFu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822
Beal, M. F. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00780-3 · Cited by 763
Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis
Kruman, I., Bruce-Keller, A. J., Bredesen, D., Waeg, G., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05089.1997 · Cited by 723
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 682
Levine, R. L. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00765-7 · Cited by 658
Protein-bound acrolein: Potential markers for oxidative stress
Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4882 · Cited by 632
Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycation
Thornalley, P. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311343 · Cited by 614
Role of reactive aldehyde in cardiovascular diseases
Uchida, K. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00226-4 · Cited by 606
Hsp70 and Hsp90—a relay team for protein folding
Wegele, H., Müller, L., & Buchner, J. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0021-1 · Cited by 605
Committee Members, Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P. C., Douglas, J. S., Ferguson, T. B., Fihn, S. D., Fraker, T. D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047041.66447.29 · Cited by 567
Acrolein Is a Product of Lipid Peroxidation Reaction
Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., & Niki, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16058 · Cited by 546
Maillard reaction products in tissue proteins: New products and new perspectives
Thorpe, S. R., & Baynes, J. W. (2003) · Amino Acids · doi:10.1007/s00726-003-0017-9 · Cited by 543
Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
The Molecular Effects of Acrolein
Kehrer, J. P. (2000) · Toxicological Sciences · doi:10.1093/toxsci/57.1.6 · Cited by 531
Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 518
Glycoxidation and lipoxidation in atherogenesis
Baynes, J. W., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 514
Modification of histidine residues in proteins by reaction with 4-hydroxynonenal.
Uchida, K., & Stadtman, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4544 · Cited by 491
Can antioxidant vitamins materially reduce oxidative damage in humans?
McCall, M. R., & Frei, B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00302-5 · Cited by 485
Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion
Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., & Bush, A. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23223 · Cited by 482
Sohal, R. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00856-0 · Cited by 478
Oxidative stress and diabetic cardiovascular complications
Jay, D., Hitomi, H., & Griendling, K. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.018 · Cited by 464
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Wardenburg, J. B., Fu, C., Jackman, J. K., Flotow, H., Wilkinson, S. E., Williams, D. H., Johnson, R., Kong, G., Chan, A. C., & Findell, P. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19641 · Cited by 463
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
Terman, A., & Brunk, U. T. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.009 · Cited by 451
Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures
Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 450
Montine, T. J., Neely, M. D., Quinn, J. F., Beal, M. F., Markesbery, W. R., Roberts, L. J., & Morrow, J. D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00807-9 · Cited by 449
Dalle‐Donne, I., Scaloni, A., Giustarini, D., Cavarra, E., Tell, G., Lungarella, G., Colombo, R., Rossi, R., & Milzani, A. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20006 · Cited by 448
Self-citationVitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous Genotoxins
Lee, S. H., Oe, T., & Blair, I. A. (2001) · Science · doi:10.1126/science.1059501 · Cited by 414
Berhane, K., Widersten, M., Engström, A., Kozarich, J. W., & Mannervik, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1480 · Cited by 413
Protein‐Bound Acrolein: A Novel Marker of Oxidative Stress in Alzheimer's Disease
Calingasan, N. Y., Uchida, K., & Gibson, G. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720751.x · Cited by 400
4-Hydroxynonenal as a bioactive marker of pathophysiological processes
Zarkovic, N. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00023-2 · Cited by 397
Pryor, W. A., & Stanley, J. P. (1975) · The Journal of Organic Chemistry · doi:10.1021/jo00912a038 · Cited by 393
Reactions of 4-hydroxynonenal with proteins and cellular targets
Petersen, D. R., & Doorn, J. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.012 · Cited by 392
Anderson, M. M., Hazen, S. L., Hsu, F. F., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119176 · Cited by 389
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
Stitt, A., Gardiner, T. A., Anderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2826 · Cited by 355
Suarna, C., Dean, R. T., May, J., & Stocker, R. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1616 · Cited by 355
Teufel, M., Saudek, V., Ledig, J.-P., Bernhardt, A., Boularand, S., Carreau, A., Cairns, N. J., Carter, C., Cowley, D. J., Duverger, D., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209764200 · Cited by 346
Novel inhibitors of advanced glycation endproducts
Rahbar, S., & Figarola, J. L. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.009 · Cited by 329
Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden
Simpson, E. P., Henry, Y. K., Henkel, J. S., Smith, R. G., & Appel, S. H. (2004) · Neurology · doi:10.1212/wnl.62.10.1758 · Cited by 327
4-Hydroxynonenal in the Pathomechanisms of Oxidative Stress
Poli, G., & Schaur, J. R. (2000) · IUBMB Life · doi:10.1080/15216540051081092 · Cited by 317
The importance of lipid-derived malondialdehyde in diabetes mellitus
Slatter, D. A., Bolton, C. H., & Bailey, A. J. (2000) · Diabetologia · doi:10.1007/s001250051342 · Cited by 317
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Forbes, J. M., Yee, L. T. L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1813 · Cited by 314
Two Distinct Pathways of Formation of 4-Hydroxynonenal
Schneider, C., Tallman, K. A., Porter, N. A., & Brash, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101821200 · Cited by 313
Chelating Activity of Advanced Glycation End-product Inhibitors
Price, D. L., Rhett, P. M., Thorpe, S. R., & Baynes, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108196200 · Cited by 308
Current Status of Acrolein as a Lipid Peroxidation Product
Uchida, K. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00016-x · Cited by 301
Carnosine and Carnosine-Related Antioxidants: A Review
Guiotto, A., Calderan, A., Ruzza, P., & Borin, G. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054864796 · Cited by 291
In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs)
Booth, A. A., Khalifah, R. G., Todd, P., & Hudson, B. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5430 · Cited by 286
Szweda, L. I., Uchida, K., Tsai, L., & Stadtman, E. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53699-1 · Cited by 285
A critical review of the literature on acrolein toxicity
Beauchamp, R. O., Andjelkovich, D. A., Kligerman, A. D., Morgan, K. T., Heck, H. D., & Feron, V. J. (1985) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448509037461 · Cited by 273
Lee, Y.-T., Hsu, C.-C., Lin, M.-H., Liu, K.-S., & Yin, M.-C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.010 · Cited by 272
Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases
Awasthi, Y. C., Yang, Y., Tiwari, N. K., Patrick, B., Sharma, A., Li, J., & Awasthi, S. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.033 · Cited by 267
Freedman, B. I., Wuerth, J.-P., Cartwright, K., Bain, R. P., Dippe, S., Hershon, K., Mooradian, A. D., & Spinowitz, B. S. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00024-0 · Cited by 259
Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction
Lucas, D. T., & Szweda, L. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.510 · Cited by 254
4-Hydroxynonenal As a Biological Signal: Molecular Basis and Pathophysiological Implications
Parola, M., Bellomo, G., Robino, G., Barrera, G., & Dianzani, M. U. (1999) · Antioxidants & Redox Signaling · doi:10.1089/ars.1999.1.3-255 · Cited by 251
McGrath, L. T. (2001) · QJM · doi:10.1093/qjmed/94.9.485 · Cited by 251
Onorato, J. M., Jenkins, A. J., Thorpe, S. R., & Baynes, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003263200 · Cited by 250
Characterization of 4-Oxo-2-nonenal as a Novel Product of Lipid Peroxidation
Lee, S. H., & Blair, I. A. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000101a · Cited by 242
Ruggiero-Lopez, D., Lecomte, M., Moinet, G., Patereau, G., Lagarde, M., & Wiernsperger, N. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00263-4 · Cited by 238
Nakamura, S., Makita, Z., Ishikawa, S., Yasumura, K., Fujii, W., Yanagisawa, K., Kawata, T., & Koike, T. (1997) · Diabetes · doi:10.2337/diab.46.5.895 · Cited by 235
Structural Definition of Early Lysine and Histidine Adduction Chemistry of 4-Hydroxynonenal
Nadkarni, D. V., & Sayre, L. M. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00044a014 · Cited by 235
Ghilarducci, D. P., & Tjeerdema, R. S. (1995) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4612-2550-8_2 · Cited by 230
Chez, M. G., Buchanan, C. P., Aimonovitch, M. C., Becker, M., Schaefer, K., Black, C., & Komen, J. (2002) · Journal of Child Neurology · doi:10.1177/08830738020170111501 · Cited by 220
Liu, W., Kato, M., Akhand, A. A., Hayakawa, A., Suzuki, H., Miyata, T., Kurokawa, K., Hotta, Y., Ishikawa, N., & Nakashima, I. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.4.635 · Cited by 217
Voziyan, P. A., Metz, T. O., Baynes, J. W., & Hudson, B. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109935200 · Cited by 216
(E)-4-Hydroxy-2-Nonenal May be Involved in the Pathogenesis of Parkinson’s Disease
Selley, M. L. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00021-5 · Cited by 215
Thornalley, P. J., Yurek-George, A., & Argirov, O. K. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00287-2 · Cited by 214
Intracellular metabolism of 4-hydroxynonenal
Siems, W., & Grune, T. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00011-6 · Cited by 212
MIYATA, T., KUROKAWA, K., & VAN YPERSELE DE STRIHOU, C. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191744 · Cited by 207
Oxygen free radicals and redox biology of organelles
Moldovan, L., & Moldovan, N. I. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0676-y · Cited by 204
Carnosine-related dipeptides in the mammalian brain
Bonfanti, L. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00010-6 · Cited by 200
Aldini, G., Facino, R. M., Beretta, G., & Carini, M. (2005) · BioFactors · doi:10.1002/biof.5520240109 · Cited by 197
Self-citationIntervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196
Carbonyl Toxicology and Alzheimer's Disease
Picklo, M. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194
Booth, A. A., Khalifah, R. G., & Hudson, B. G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0366 · Cited by 191
Metz, T. O., Alderson, N. L., Thorpe, S. R., & Baynes, J. W. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.021 · Cited by 191
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy
Corman, B., Duriez, M., Poitevin, P., Heudes, D., Bruneval, P., Tedgui, A., & Levy, B. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1301 · Cited by 190
New insights on oxidative stress in the artery wall
STOCKER, R., & KEANEY, J. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01370.x · Cited by 188
Miyata, T., Ueda, Y., Yamada, Y., Izuhara, Y., Wada, T., Jadoul, M., Saito, A., Kurokawa, K., & van Ypersele de Strihou, C. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9122349 · Cited by 188
Voziyan, P. A., & Hudson, B. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5082-7 · Cited by 187
Metformin inhibition of glycation processes
Beisswenger, P., & Ruggiero-Lopez, D. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72793-1 · Cited by 182
Dei, R., Takeda, A., Niwa, H., Li, M., Nakagomi, Y., Watanabe, M., Inagaki, T., Washimi, Y., Yasuda, Y., Horie, K., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0523-y · Cited by 179
Carini, M., Aldini, G., & Facino, R. M. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.10076 · Cited by 177
Self-citationCarbone, D. L., Doorn, J. A., Kiebler, Z., Ickes, B. R., & Petersen, D. R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088088 · Cited by 175
The cytotoxic mechanism of glyoxal involves oxidative stress
Shangari, N., & O’Brien, P. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.013 · Cited by 174
Pyrrole formation from 4-hydroxynonenal and primary amines
Sayre, L. M., Arora, P. K., Iyer, R. S., & Salomon, R. G. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00031a002 · Cited by 174
Carnosine, a protective, anti-ageing peptide?
Hipkiss, A. R. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00060-0 · Cited by 171
Alderson, N. L., Chachich, M. E., Youssef, N. N., Beattie, R. J., Nachtigal, M., Thorpe, S. R., & Baynes, J. W. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00027.x · Cited by 171
Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction?
Aldini, G., Carini, M., Beretta, G., Bradamante, S., & Facino, R. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02545-7 · Cited by 170
Self-citationGenotoxic properties of 4-hydroxyalkenals and analogous aldehydes
Eckl, P. M., Ortner, A., & Esterbauer, H. (1993) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(93)90158-c · Cited by 164
4-Oxo-2-nonenal Is Both More Neurotoxic and More Protein Reactive than 4-Hydroxy-2-nonenal
Lin, D., Lee, H.-G., Liu, Q., Perry, G., Smith, M. A., & Sayre, L. M. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050080q · Cited by 164
4-Hydroxynonenal inhibits Na+-K+-ATPase
Siems, W. G., Hapner, S. J., & Van Kuijk, F. J. G. M. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02041-1 · Cited by 161
The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Thomas, M., Baynes, J., Thorpe, S., & Cooper, M. (2005) · Current Drug Targets · doi:10.2174/1389450054021873 · Cited by 159
Zeng, J., & Davies, M. J. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050074u · Cited by 157
Brambilla, G., Sciabà, L., Faggin, P., Maura, A., Marinari, U. M., Ferro, M., & Esterbauer, H. (1986) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(86)90051-0 · Cited by 155
Gardner, M. L. G., Illingworth, K. M., Kelleher, J., & Wood, D. C. F. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018673 · Cited by 154
Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal
Doorn, J. A., & Petersen, D. R. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00178-3 · Cited by 153
Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation
Rahbar, S., Natarajan, R. D., Yerneni, K. K. V., Scott, S., Gonzales, N., & Nadler, J. L. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00327-2 · Cited by 152
Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups
Hipkiss, A. R., Brownson, C., & CARRIER, M. J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00272-x · Cited by 151
Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes
Jagt, D. L. V., Hunsaker, L. A., Jagt, T. J. V., Gomez, M. S., Gonzales, D. M., Deck, L. M., & Royer, R. E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00090-7 · Cited by 146
Lederer, M. O., & Klaiber, R. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00212-6 · Cited by 146
Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.
Carbone, D., Doorn, J., Kiebler, Z., & Petersen, D. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050078z · Cited by 144
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart
Eaton, P., Li, J., Hearse, D. J., & Shattock, M. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.3.h935 · Cited by 143
Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways
Alary, J., Guéraud, F., & Cravedi, J. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00012-8 · Cited by 143
Modification of Proteins In Vitro by Physiological Levels of Glucose
Voziyan, P., Khalifah, R. G., Thibaudeau, C., Yıldız, A., Jacob, J., Serianni, A. S., & Hudson, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307155200 · Cited by 143
Odani, H., Shinzato, T., Usami, J., Matsumoto, Y., Frye, E. B., Baynes, J., & Maeda, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00416-5 · Cited by 142
Carnosine Protects Proteins against Methylglyoxal-Mediated Modifications
Hipkiss, A. R., & Chana, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8806 · Cited by 141
Miyata, T., Inagi, R., Asahi, K., Yamada, Y., Horie, K., Sakai, H., Uchida, K., & Kurokawa, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01079-5 · Cited by 140
Signaling kinases modulated by 4-hydroxynonenal
Leonarduzzi, G., Robbesyn, F., & Poli, G. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.027 · Cited by 139
Role of 4-Hydroxynonenal in Modification of Cytochrome c Oxidase in Ischemia/Reperfused Rat Heart
Chen, J., Henderson, G. I., & Freeman, G. L. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1454 · Cited by 138
Dietary Glutathione Protects Rats from Diabetic Nephropathy and Neuropathy
Ueno, Y., Sumi, H., Osawa, T., Kizaki, M., NAKAGIRI, R., & Kamiya, T. (2002) · Journal of Nutrition · doi:10.1093/jn/132.5.897 · Cited by 137
α-Hydroxyaldehydes, products of lipid peroxidation
Loidl‐Stahlhofen, A., & Spitelier, G. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90264-x · Cited by 135
Rindgen, D., Nakajima, M., Wehrli, S. L., et al. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990034o · Cited by 134
Akhand, A. A., Hossain, K., Mitsui, H., Kato, M., Miyata, T., Inagi, R., Du, J., Takeda, K., Kawamoto, Y., Suzuki, H., et al. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00550-0 · Cited by 134
Pathobiological effects of acrolein in cultured human bronchial epithelial cells.
Grafström, R., Dypbukt, J. M., Willey, J. C., Sundqvist, K., Edman, C. C., Atzori, L., & Harris, C. C. (1988) · PubMed · Cited by 130
Quantitation of Carnosine in Humans Plasma after Dietary Consumption of Beef
Park, Y.-J., Volpe, S. L., & Decker, E. A. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf047934h · Cited by 129
Inhibition of adenine nucleotide translocator by lipid peroxidation products
Chen, J. J., Bertrand, H. A., & Yu, B. P. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00066-7 · Cited by 126
Nair, V., Vietti, D. E., & Cooper, C. S. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a020 · Cited by 125
Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")
Miyata, T., Sugiyama, S., Saitō, A., & Kurokawa, K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780025.x · Cited by 124
Catalytic site‐specific inhibition of the 20S proteasome by 4‐hydroxynonenal
Ferrington, D. A., & Kapphahn, R. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.003 · Cited by 121
Krokan, H. E., Grafström, R. C., Sundqvist, K., Esterbauer, H., & Harris, C. C. (1985) · Carcinogenesis · doi:10.1093/carcin/6.12.1755 · Cited by 121
Efficacy of Dietary Antioxidants to Prevent Oxidative Damage and Inhibit Chronic Disease
Frei, B. B. (2004) · Journal of Nutrition · doi:10.1093/jn/134.11.3196s · Cited by 120
Cohn, J. A., Tsai, L., Friguet, B., & Szweda, L. I. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0156 · Cited by 120
Ishii, T., Tatsuda, E., Kumazawa, S., Nakayama, T., & Uchida, K. (2003) · Biochemistry · doi:10.1021/bi027172o · Cited by 118
Zhou, S., & Decker, E. A. (1998) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980780j · Cited by 116
Inhibition of Hsp72-Mediated Protein Refolding by 4-Hydroxy-2-nonenal
Carbone, D. L., Doorn, J. A., Kiebler, Z., Sampey, B. P., & Petersen, D. R. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049838g · Cited by 116
Yamagishi, S., Takeuchi, M., Inagaki, Y., Nakamura, K., & Imaizumi, T. (2003) · PubMed · Cited by 114
Pyridoxamine Traps Intermediates in Lipid Peroxidation Reactions in Vivo
Metz, T., Alderson, N. L., Chachich, M. E., Thorpe, S. R., & Baynes, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304292200 · Cited by 112
Nϵ-(3-Methylpyridinium)lysine, a Major Antigenic Adduct Generated in Acrolein-modified Protein
Furuhata, A., Ishii, T., Kumazawa, S., Yamada, T., Nakayama, T., & Uchida, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309401200 · Cited by 112
Millar, A. H., & Leaver, C. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01976-1 · Cited by 112
Hipkiss, A. R., Preston, J. E., Himswoth, D. T. M., Worthington, V., & Abbott, N. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00873-2 · Cited by 111
Acrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease
Pocernich, C. B., & Butterfield, D. A. (2003) · Neurotoxicity Research · doi:10.1007/bf03033161 · Cited by 111
Isolation and Characterization of Glyoxal−Arginine Modifications
Glomb, M. A., & Lang, G. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf001082d · Cited by 109
Thiolation of Protein-bound Carcinogenic Aldehyde
Furuhata, A., Nakamura, M., Osawa, T., & Uchida, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202794200 · Cited by 108
Identification of α-dicarbonyl scavengers for cellular protection against carbonyl stress
Wondrak, G. T., Cervantes-Laurean, D., Roberts, M. J., Qasem, J. G., Kim, M., Jacobson, E. L., & Jacobson, M. K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00915-7 · Cited by 108
Model Studies on Protein Side Chain Modification by 4-Oxo-2-nonenal
Zhang, W., Liu, J., Xu, G., Yuan, Q., & Sayre, L. M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx020105a · Cited by 107
Jagt, D. L. V., Hassebrook, R. K., Hunsaker, L. A., Brown, W. M., & Royer, R. E. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00298-2 · Cited by 107
Picard, S., Parthasarathy, S., Fruebis, J., & Witztum, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6876 · Cited by 107
PURIFICATION AND CHARACTERIZATION OF CARNOSINE SYNTHETASE FROM MOUSE OLFACTORY BULBS
Horinishi, H., Grillo, M., & Margolis, F. L. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb00127.x · Cited by 106
Protein Carbonyl Formation in the Diaphragm
Barreiro, E., Gea, J., Falco, M. D., Kriazhev, L., James, S., & Hussain, S. N. A. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0021oc · Cited by 105
Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues
Crabb, J. W., O'NEIL, J. A., Miyagi, M., West, K. A., & Hoff, H. F. (2002) · Protein Science · doi:10.1110/ps.4400102 · Cited by 105
Hydroxynonenal, toxic carbonyls, and Alzheimer disease
Liu, Q., Raina, A. K., Smith, M. A., Sayre, L. M., & Perry, G. L. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00025-6 · Cited by 104
Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products
Burcham, P. C., Kaminskas, L. M., Fontaine, F. R., Petersen, D. R., & Pyke, S. M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00287-1 · Cited by 104
Toraason, M. A., Luken, M. E., Breitenstein, M. J., KRUEGER, J. A., & Biagini, R. E. (1989) · Toxicology · doi:10.1016/0300-483x(89)90216-3 · Cited by 103
Serum 4-Hydroxy-2-Nonenal-Modified Albumin Is Elevated in Patients with Type 2 Diabetes Mellitus
Toyokuni, S., Yamada, S., Kashima, M., Ihara, Y., Yamada, Y., Tanaka, T., Hiai, H., Seino, Y., & Uchida, K. (2000) · Antioxidants and Redox Signaling · doi:10.1089/ars.2000.2.4-681 · Cited by 102
Carbonyl Stress in the Pathogenesis of Diabetic Nephropathy.
SUZUKI, D., & Miyata, T. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.309 · Cited by 99
Reactive Oxygen and Nitrogen Species in Alzheimers Disease
Aslan, M., & Özben, T. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332162 · Cited by 97
Odetti, P. R., Pesce, C. M., Traverso, N., Menini, S., Maineri, E. P., Cosso, L., Valentini, S., Patriarca, S., Cottalasso, D., Marinari, U. M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.499 · Cited by 97
Scott, S., Loera, S., Tessler, C., Chu, P., Weiss, L. M., Hardy, J. W., Rahbar, S., & Figarola, J. L. (2003) · Diabetologia · doi:10.1007/s00125-003-1162-0 · Cited by 96
Alderson, N. L., Chachich, M. E., Frizzell, N., Canning, P., Metz, T., Januszewski, A. S., Youssef, N., Stitt, A. W., Baynes, J., & Thorpe, S. R. (2004) · Diabetologia · doi:10.1007/s00125-004-1474-8 · Cited by 96
Reaction of Carnosine with Aged Proteins: Another Protective Process?
Hipkiss, A. R., BROWNSON, C., BERTANI, M. F., RUIZ, E., & Ferro, A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02100.x · Cited by 96
Nϵ-Carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease
Gironès, X., Guimerá, A., Cruz-Sánchez, C.-Z., Aznar, A. O., Sasaki, N., Makita, Z., Lafuente, J. V., Kalaria, R. N., & Cruz-Sánchez, F. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.006 · Cited by 95
Slatter, D. A., Murray, M., & Bailey, A. J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01554-8 · Cited by 95
McArdle, F., Rhodes, L. E., Parslew, R., Close, G. L., Jack, C. I. A., Friedmann, P. S., & Jackson, M. J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1270 · Cited by 95
Toxicity of glyoxals – role of oxidative stress, metabolic detoxification and thiamine deficiency
Shangari, N., Bruce, W. R., Poon, R. W. M., & O'Brien, P. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311390 · Cited by 94
Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy
Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., YASUMURA, K., Nakano, M., & Yagihashi, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00826.x · Cited by 93
Wells‐Knecht, K. J., Brinkmann, E., & Baynes, J. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00125a001 · Cited by 93
A possible new role for the anti-ageing peptide carnosine
Hipkiss, A. R., & Brownson, C. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050039 · Cited by 92
Carini, M., Aldini, G., Beretta, G., ARLANDINI, E., & Facino, R. M. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.517 · Cited by 91
Self-citationOxidants and Antioxidants in Cutaneous Biology
Thiele, J. J., & Elsner, P. U. (2000) · Current problems in dermatology · doi:10.1159/isbn.978-3-318-00629-2 · Cited by 90
Miyata, T., Ueda, Y., Asahi, K., Izuhara, Y., Inagi, R., Saitō, A., de Strihou, C. V. Y., & Kurokawa, K. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191719 · Cited by 90
Musatov, A., Carroll, C. A., Liu, Y.-C., Henderson, G. I., Weintraub, S. T., & Robinson, N. C. (2002) · Biochemistry · doi:10.1021/bi025896u · Cited by 88
Reinvestigation of lipid peroxidation of linolenic acid
Miakar, A., & Spiteller, G. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90046-9 · Cited by 87
Nguyen, A., & Donaldson, R. P. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.04.018 · Cited by 85
Bell, C. G., Benzinou, M., Siddiq, A., Lecœur, C., Dina, C., Lemainque, A., Clément, K., Basdevant, A., Guy-grand, B., Mein, C. A., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1857 · Cited by 84
Penicillamine: Review and cutaneous manifestations
Levy, R. S., FISHER, M. S., & Alter, J. N. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)70062-9 · Cited by 83
Carnosine as a potential anti-senescence drug.
Gallant, S., SEMYONOVA, M. L., & Yuneva, M. O. (2000) · PubMed · Cited by 82
Liu, Y. A., Xu, G., & Sayre, L. M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034160a · Cited by 81
McCall, M. R., Tang, J. Y., Bielicki, J. K., & Forte, T. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1599 · Cited by 81
Miyata, T., Ishikawa, S., Asahi, K., Inagi, R., Suzuki, D., Horie, K., Tatsumi, K., & Kurokawa, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00122-2 · Cited by 80
The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure–activity study
Meade, S. J., Miller, A. G., & Gerrard, J. A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00564-3 · Cited by 79
Orioli, M., Aldini, G., Beretta, G., Facino, R. M., & Carini, M. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.025 · Cited by 79
Self-citationSalomon, R. G., Batyreva, E., Kaur, K., Sprecher, D. L., Schreiber, M. J., Crabb, J. W., Penn, M. S., DiCorleto, A. M., Hazen, S. L., & Podrez, E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00038-x · Cited by 78
Reactions of Lipid-derived Malondialdehyde with Collagen
Slatter, D. A., Paul, R. G., Murray, M., & Bailey, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19661 · Cited by 78
Cited by
Tsikas, D. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2016.10.021 · Cited by 2,190
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., & Aldini, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.815348 · Cited by 823
Self-citationTrevisani, M., Siemens, J., Materazzi, S., Bautista, D. M., Nassini, R., Campi, B., Imamachi, N., Andrè, E., Patacchini, R., Cottrell, G. S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705923104 · Cited by 770
Biomarkers of Oxidative Stress and Antioxidant Defense
Demirci-Çekiç, S., Özkan, G., Avan, A. N., Uzunboy, S., Çapanoğlu, E., & Apak, R. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114477 · Cited by 587
Metadata
- Authors
- Aldini, G., Dalle‐Donne, I., Facino, R. M., Milzani, A., & Carini, M.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2006-10-16
- Volume
- 27
- Issue
- 6
- Pages
- 817-868
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2949582036
- Cited by
- 289
- References
- 271
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.